Original Articles

Establishment of a cytopathology unit and implementation of HPV genotyping for cervical cancer screening at the University Hospital Complex “Le Bon Samaritain”, N’Djamena, Chad

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 December 2025
187
Views
71
Downloads
80
HTML

Authors

Cervical cancer remains one of the leading causes of death among women in Sub-Saharan Africa, particularly in Chad, where access to screening and qualified personnel is limited. This study aimed to describe the implementation process of a cytopathology unit and human papillomavirus (HPV) genotyping dedicated to the screening of cervical (pre)cancerous lesions at the “Le Bon Samaritain” University Hospital Complex (CHU-BS) in N’Djamena, Chad, as well as the challenges faced and the lessons learned. The intervention followed four phases: needs assessment, procurement and installation of essential equipment, intensive training of local staff, and a pilot screening campaign. Telecytology was integrated to support remote validation by external experts. In parallel, a qualitative HPV genotyping protocol was implemented using the BioPerfectus real-time polymerase chain reaction (PCR) kit (BioPerfectus Technologies Co., Ltd.). A functional two-room cytology unit was established, and local staff were trained to independently prepare and stain smears. Telecytology enables rapid validation and capacity building. During a 10-day campaign, 284 women were screened. Among the 47 slides reviewed, 14 showed cytological abnormalities. HPV genotyping was performed on six samples, of which two tested positive, identifying seven high-risk genotypes (HPV16, 35, 45, 52, 58, 66, 68), one low-risk genotype (HPV6), and multiple infections. The main challenges faced were limited equipment and supply shortages, which were successfully addressed through adaptive solutions and collaborative efforts. This experience demonstrates that establishing a functional cytopathology service and implementing HPV genotyping is feasible in resource-limited settings through collaboration, tailored training, and adaptive use of available resources. The CHU-BS model provides a practical cancer screening service in Chad and similar Sahelian contexts.

Downloads

Download data is not yet available.

Citations

Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-63. DOI: https://doi.org/10.3322/caac.21834
Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in Africa: a systematic review. BMC Public Health 2024;24:525. DOI: https://doi.org/10.1186/s12889-024-17842-1
World Health Organization. Cervical cancer elimination initiative: global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. 1st ed. Geneva: World Health Organization; 2021 [cited 2025 Oct 18]. Available from: https://iris.who.int/server/api/core/bitstreams/96b1ee46-ab05-4e35-b4b0-cf84c8bce41d/content
Mortier E, Doudéadoum N, Némian F, et al. Faisabilité du frottis cervico-utérin chez les femmes séropositives pour le VIH vivant au Tchad. Bull Soc Pathol Exot 2016;109:180-4. DOI: https://doi.org/10.1007/s13149-016-0496-z
International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today [Internet]. Lyon: IARC; 2024 [cited 2025 Oct 18]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/148-chad-fact-sheet.pdf
Pangarkar MA. The Bethesda System for reporting cervical cytology. CytoJournal 2022;19:28. DOI: https://doi.org/10.25259/CMAS_03_07_2021
Nayar R, Wilbur DC, editors. The Bethesda System for reporting cervical cytology: definitions, criteria, and explanatory notes [Internet]. Cham: Springer International Publishing; 2015 [cited 2025 Nov 11]. Available from: https://link.springer.com/10.1007/978-3-319-11074-5 DOI: https://doi.org/10.1007/978-3-319-11074-5
Marck VM. Manuel de techniques d’anatomo-cytopathologie. Paris: Elsevier Masson; 2010. DOI: https://doi.org/10.1016/B978-2-294-70844-2.00002-2
QIAGEN. QIAamp® DNA Mini and Blood Mini Handbook [Internet]. 2025 [cited 2025 Oct 28]. Available from: https://www.qiagen.com/ai/resources/resourcedetail?id=62a200d6-faf4-469b-b50f-2b59cf738962&lang=en
BioPerfectus. Human papillomavirus genotyping real-time PCR kit [Internet]. [cited 2025 Dec 13]. Available from: https://www.bioperfectus.com/ProductDetail/HumanPapillomavirusGenotypingRealTimePCRKit
Dezoumbe K, Suitombaye NY, Routoubé M, et al. Four years after its creation: what role for the Laboratoire des Grandes Épidémies Tropicales (LAGET) in epidemic response in Chad? Sahelian J Responsible One Health 2025;1. DOI: https://doi.org/10.4081/sjroh.2025.538
World Health Organization. Cytological screening in the control of cervical cancer: technical guidelines [Internet]. Geneva: World Health Organization; 1988. 52 p. Available from: https://iris.who.int/handle/10665/39794
Lycke KD, Steben M, Garland SM, et al. An updated understanding of the natural history of cervical human papillomavirus infection—clinical implications. Am J Obstet Gynecol 2025;232:453-60. DOI: https://doi.org/10.1016/j.ajog.2025.02.029
Michalas SP. The Pap test: George N. Papanicolaou (1883–1962). Eur J Obstet Gynecol Reprod Biol 2000;90:135-8. DOI: https://doi.org/10.1016/S0301-2115(00)00260-8
Fitzhugh VA, Heller DS. Significance of a diagnosis of microorganisms on Pap smear. J Low Genit Tract Dis 2008;12:40-51. DOI: https://doi.org/10.1097/lgt.0b013e31813e07ff
Sarbhai V, Aggarwal S. Cervical cancer screening: comparing PAP smear with VIA/VILI in semiurban women of Delhi. Indian J Med Paediatr Oncol 2025;46:200-6. DOI: https://doi.org/10.1055/s-0044-1800949
Organisation mondiale de la Santé. La lutte contre le cancer du col de l’utérus: guide des pratiques essentielles [Internet]. 2e éd. Genève: Organisation mondiale de la Santé; 2017 [cited 2025 Oct 18]. Available from: https://iris.who.int/server/api/core/bitstreams/44c39bc2-2595-4744-937c-05bdc3282d43/content
Rajaram S, Gupta B. Screening for cervical cancer: choices and dilemmas. Indian J Med Res 2021;154:210-20. DOI: https://doi.org/10.4103/ijmr.IJMR_857_20
Singh S, Badaya S. Tele-cytology: an innovative approach for cervical cancer screening in resource-poor settings. J Cancer Res Ther 2016;12:481. DOI: https://doi.org/10.4103/0973-1482.157343
Pereira CR, Gebbers JO. Establishing a cytology laboratory in a low-resource setting for cervical cancer screening. Riv Ital Med Lab 2012;8:239-44. DOI: https://doi.org/10.1007/s13631-012-0065-9
Boaz M, Febian N, Bary AD, et al. Setting up a cytology laboratory for cervical cancer screening in a developing country: a one-year early experience at a private facility [Internet]. Preprint; 2021 [cited 2025 Nov 11]. Available from: https://www.researchsquare.com/article/rs-804082/v1 DOI: https://doi.org/10.21203/rs.3.rs-804082/v1
Henke O, Qader AQ, Malle GL, et al. International cooperation to fight cancer’s late-stage presentation in low- and middle-income countries. Clin Exp Metastasis 2023;40:1-3. DOI: https://doi.org/10.1007/s10585-022-10196-1
Tchouaket MCT, Fokam J, Sosso SM, et al. High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness. IJID Reg 2022;5:130-6. DOI: https://doi.org/10.1016/j.ijregi.2022.09.014
Bouassa RSM, Ntsigouaye JA, Tsimba PCL, et al. Genetic diversity of HPV35 in Chad and the Central African Republic: a cross-sectional study. PLoS One 2024;19:e0297054. DOI: https://doi.org/10.1371/journal.pone.0297054
Tsimba Lemba PC, Boumba LMA, Péré H, et al. Human papillomavirus genotype distribution by cytological status and associated risk factors in Congolese women living in urban and rural areas: implications for cervical cancer prevention. Infect Dis Now 2023;53:104762. DOI: https://doi.org/10.1016/j.idnow.2023.104762

Supporting Agencies

The cytopathology unit was established thanks to the Italy-Chad Health Project –Training and Technological Innovation (AID12582), implemented by the MAGIS Foundation.
Monique Routoubé, Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Faculty of Science and Technology, Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon.

Koutaya Dezoumbe, Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena; Faculty of Medicine, University Hospital Complex “Le Bon Samaritain”, N’Djamena

Faculty of Science and Technology, Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon.

Sabrina Atturo, Italian Jesuit Movement and Action for Development Foundation, Rome

Laboratoire des Grandes Épidémies Tropicales, University Hospital Complex “Le Bon Samaritain”, N’Djamena, Chad.

Camino Pérez Garrido, Department of Gynecology, Jiménez Díaz Foundation Hospital, Madrid

Department of Gynecology, University Hospital Complex “Le Bon Samaritain”, N’Djamena, Chad.

Alaric Talom Tamuedjoun, Faculty of Science and Technology, Evangelical University of Cameroon, Mbouo-Bandjoun; Laboratory of Pathology, Evangelical University Institute of Cameroon, Mbouo-Bandjoun

Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.

How to Cite



Establishment of a cytopathology unit and implementation of HPV genotyping for cervical cancer screening at the University Hospital Complex “Le Bon Samaritain”, N’Djamena, Chad. (2025). Sahelian Journal of Responsible One Health, 1(3). https://doi.org/10.4081/sjroh.2025.603